Popping a pill could fix gene defect

Popping a pill could fix gene defect Simply popping a pill might be enough to overcome the type of genetic defect responsible for many cases of cystic fibrosis, muscular dystrophy and haemophilia. An experimental drug called PTC124 produces a working protein even though the gene remains defective.


Monsanto Overhauling Businesses

Monsanto Overhauling Businesses Monsanto, the world’s leading agricultural biotechnology company, says it is abandoning efforts to produce pharmaceuticals in genetically engineered crops to focus on businesses that could pay off sooner.


Get email updates

Get new actionable insights and updates from BiotechBlog

Biotechblog